Trials / Completed
CompletedNCT05416151
Effect of B.Lactis Consumption on Gastro-Intestinal (GI) Symptoms in Healthy Women Reporting Minor GI Symptoms
Evaluation of the Effect of a 28-day B.Lactis Consumption Twice Daily on Gastro-Intestinal (GI) Symptoms in Healthy Women Reporting Minor GI Symptoms. A Proof of Efficacy, Randomized, Controlled, Double-blind, Parallel Arms, Adaptive Design.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 486 (actual)
- Sponsor
- Danone Global Research & Innovation Center · Industry
- Sex
- Female
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess the effect of a 28-day B.lactis consumption twice daily on Gastro-Intestinal (GI) symptoms in healthy women reporting minor GI symptoms.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Freeze-dried biotic | 2 sticks of 3g consumed daily for 28 days |
| OTHER | Maltodextrin | 2 sticks of 3g consumed daily for 28 days |
Timeline
- Start date
- 2022-05-24
- Primary completion
- 2023-12-15
- Completion
- 2024-04-18
- First posted
- 2022-06-13
- Last updated
- 2024-08-09
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05416151. Inclusion in this directory is not an endorsement.